PT852497E - Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas - Google Patents

Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas

Info

Publication number
PT852497E
PT852497E PT96929216T PT96929216T PT852497E PT 852497 E PT852497 E PT 852497E PT 96929216 T PT96929216 T PT 96929216T PT 96929216 T PT96929216 T PT 96929216T PT 852497 E PT852497 E PT 852497E
Authority
PT
Portugal
Prior art keywords
combination
pct
antibiotics
utilization
treatment
Prior art date
Application number
PT96929216T
Other languages
English (en)
Inventor
Peter Scholz
Jorg Weber
Klemens Angstwurm
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT852497E publication Critical patent/PT852497E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT96929216T 1995-08-11 1996-08-06 Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas PT852497E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19530884A DE19530884C2 (de) 1995-08-11 1995-08-11 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Meningitis

Publications (1)

Publication Number Publication Date
PT852497E true PT852497E (pt) 2002-10-31

Family

ID=7770106

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96929216T PT852497E (pt) 1995-08-11 1996-08-06 Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas

Country Status (25)

Country Link
US (1) US6040336A (pt)
EP (1) EP0852497B1 (pt)
JP (1) JPH11510809A (pt)
CN (1) CN1080562C (pt)
AT (1) ATE219368T1 (pt)
AU (1) AU702706B2 (pt)
BR (1) BR9609932A (pt)
CA (1) CA2228036A1 (pt)
CZ (1) CZ291534B6 (pt)
DE (2) DE19530884C2 (pt)
DK (1) DK0852497T3 (pt)
ES (1) ES2181907T3 (pt)
HK (1) HK1015707A1 (pt)
HU (1) HUP9802450A3 (pt)
IL (1) IL122826A (pt)
MX (1) MX9801118A (pt)
NO (1) NO316424B1 (pt)
PL (1) PL184840B1 (pt)
PT (1) PT852497E (pt)
RU (1) RU2201232C2 (pt)
SK (1) SK284195B6 (pt)
TR (1) TR199800128T1 (pt)
UA (1) UA54397C2 (pt)
WO (1) WO1997006806A1 (pt)
ZA (1) ZA966775B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6663967B1 (en) * 2000-11-17 2003-12-16 Bryant Rubber Corporation Moldable silicone elastomers having selective primerless adhesion
WO2008058766A1 (en) * 2006-11-16 2008-05-22 Bayer Schering Pharma Aktiengesellschaft Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection
EP2803365A1 (en) 2013-05-14 2014-11-19 Commissariat A L'energie Atomique Et Aux Energies Alternatives Use of clonazepam in combination with antibiotic in the treatment of bacterially induced meningitis
WO2021163400A1 (en) 2020-02-12 2021-08-19 Cytoagents, Inc. Compositions and methods for treating coronavirus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US447802A (en) * 1891-03-10 Irvest williams
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
US4665088A (en) * 1984-11-14 1987-05-12 The Research Foundation Of State University Of New York (E-Z)-4,5,9-trithiadodeca-1,6,11-triene 9-oxides
ZA871143B (en) * 1986-02-18 1988-09-28 Syntex Inc Anti-infective injectable formulations
DE4104607A1 (de) * 1991-02-12 1992-08-13 Schering Ag Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen
ATE255413T1 (de) * 1994-04-21 2003-12-15 Schering Ag Pde iv-inhibitoren zur behandlung der multiplen sklerose

Also Published As

Publication number Publication date
CN1080562C (zh) 2002-03-13
IL122826A0 (en) 1998-08-16
CZ291534B6 (cs) 2003-03-12
AU6871196A (en) 1997-03-12
SK284195B6 (sk) 2004-10-05
EP0852497B1 (en) 2002-06-19
NO980568D0 (no) 1998-02-10
PL184840B1 (pl) 2002-12-31
CN1192684A (zh) 1998-09-09
HUP9802450A2 (hu) 1999-02-01
DE19530884A1 (de) 1997-02-20
RU2201232C2 (ru) 2003-03-27
HUP9802450A3 (en) 1999-08-30
DE69621939T2 (de) 2003-01-09
HK1015707A1 (en) 1999-10-22
CA2228036A1 (en) 1997-02-27
ATE219368T1 (de) 2002-07-15
NO980568L (no) 1998-02-10
WO1997006806A1 (en) 1997-02-27
SK15698A3 (en) 1998-06-03
DE19530884C2 (de) 1997-07-31
DE69621939D1 (de) 2002-07-25
UA54397C2 (uk) 2003-03-17
ES2181907T3 (es) 2003-03-01
DK0852497T3 (da) 2002-08-12
AU702706B2 (en) 1999-03-04
NO316424B1 (no) 2004-01-26
EP0852497A1 (en) 1998-07-15
PL324884A1 (en) 1998-06-22
ZA966775B (en) 1997-02-19
TR199800128T1 (xx) 1998-04-21
US6040336A (en) 2000-03-21
JPH11510809A (ja) 1999-09-21
CZ41498A3 (cs) 1998-09-16
BR9609932A (pt) 1999-06-08
IL122826A (en) 2001-11-25
MX9801118A (es) 1998-10-31

Similar Documents

Publication Publication Date Title
PT688789E (pt) Processo de lipopeptideos processo para a sua preparacao e sua utilizacao
NZ506058A (en) Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
AP9801283A0 (en) Carbamoyloxy derivatives of mutiline and their use as antibacterials.
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
ATE161265T1 (de) Derivate von 16-gliedrigen antibiotischen macroliden
NZ504503A (en) Oxazolidinone derivatives and pharmaceutical use as antimicrobial agents
PL358666A1 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
AR005642A1 (es) Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios
FI962488A (fi) HIV:n proteaasin inhibiittoreita
DK312688D0 (da) Glykkopeptid-antibiotika
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
DE69615155D1 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
DK0801655T3 (da) Basiske prolinamidderivater af GE 2270 og GE 2270-lignende antibiotika
PT852497E (pt) Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas
DE60030300D1 (de) Topische behandlung zur vorbeugung von augeninfektionen
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
NO890287D0 (no) Fremstilling av beta-laktam-antibiotika.
AP9701040A0 (en) Novel compounds.